Disseminated intravascular coagulation in advanced lung adenocarcinoma during first-line pembrolizumab

被引：11

作者：

Alberti, Andrea ^{[1
]}

Mancin, Maddalena ^{[1
]}

Cortinovis, Diego ^{[1
]}

Bidoli, Paolo ^{[1
]}

Sala, Luca ^{[1
]}

机构：

[1] Asst Monza, Dept Oncol, San Gerardo Hosp, Via Pergolesi 33, Monza, Italy

来源：

IMMUNOTHERAPY | 2020年 / 12卷 / 09期

关键词：

adenocarcinoma; coagulation-fibrinolysis system; disseminated intravascular coagulation; immune-related adverse events; immune checkpoint inhibitors; immunotherapy; lung cancer; pembrolizumab; programmed death 1; tissue factor; DIAGNOSIS;

D O I：

10.2217/imt-2020-0018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Aim: Every year 1.6 million people worldwide die from lung cancer, making it one of the most frequent and deadly tumors. Pembrolizumab is a humanized monoclonal antibody against PD-1 that has antitumor activity in advanced non-small-cell lung cancer, with increased activity in tumors that express programmed death ligand 1. Methods & results: We report the first case of pembrolizumab-related disseminated intravascular coagulation (DIC). After excluding other causes of DIC, a diagnosis of pembrolizumab-related DIC was performed and the patient was treated with corticosteroid therapy until signs resolution. Conclusion: Disorders of coagulation-fibrinolysis system related to immunotherapy are rare, but often clinically serious and life threatening, so it is necessary to pay close attention to the various symptoms and signs during immunotherapy.

引用

页码：629 / 633

页数：5

共 13 条

[1] Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway [J].

Boussiotis, Vassiliki A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18) :1767-1778

[2]

Davis EJ, 2019, ONCOLOGIST, V24, P1

[3]

Delanoy N, 2018, LANCET HAEMATOL, V3026, P1

[4] Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer [J].

Garon, Edward B. ;

Rizvi, Naiyer A. ;

Hui, Rina ;

Leighl, Natasha ;

Balmanoukian, Ani S. ;

Eder, Joseph Paul ;

Patnaik, Amita ;

Aggarwal, Charu ;

Gubens, Matthew ;

Horn, Leora ;

Carcereny, Enric ;

Ahn, Myung-Ju ;

Felip, Enriqueta ;

Lee, Jong-Seok ;

Hellmann, Matthew D. ;

Hamid, Omid ;

Goldman, Jonathan W. ;

Soria, Jean-Charles ;

Dolled-Filhart, Marisa ;

Rutledge, Ruth Z. ;

Zhang, Jin ;

Lunceford, Jared K. ;

Rangwala, Reshma ;

Lubiniecki, Gregory M. ;

Roach, Charlotte ;

Emancipator, Kenneth ;

Gandhi, Leena .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21) :2018-2028

[5] Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial [J].

Herbst, Roy S. ;

Baas, Paul ;

Kim, Dong-Wan ;

Felip, Enriqueta ;

Perez-Gracia, Jose L. ;

Han, Ji-Youn ;

Molina, Julian ;

Kim, Joo-Hang ;

Arvis, Catherine Dubos ;

Ahn, Myung-Ju ;

Majem, Margarita ;

Fidler, Mary J. ;

de Castro, Gilberto, Jr. ;

Garrido, Marcelo ;

Lubiniecki, Gregory M. ;

Shentu, Yue ;

Im, Ellie ;

Dolled-Filhart, Marisa ;

Garon, Edward B. .

LANCET, 2016, 387 (10027) :1540-1550

[6] Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient [J].

Horio, Yuko ;

Takamatsu, Koutaro ;

Tamanoi, Daisuke ;

Sato, Ryo ;

Saruwatari, Koichi ;

Ikeda, Tokunori ;

Nakane, Shunya ;

Nakajima, Makoto ;

Saeki, Sho ;

Ichiyasu, Hidenori ;

Fujii, Kazuhiko ;

Tomita, Yusuke .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (10) :1764-1767

[7] Pathogenesis and diagnosis of disseminated intravascular coagulation [J].

Levi, M. .

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 :15-20

[8] Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors [J].

Ouchi, Kota ;

Takahashi, Shin ;

Chikamatsu, Sonoko ;

Ito, Shukuei ;

Takahashi, Yoshikazu ;

Kawai, Sadayuki ;

Okita, Akira ;

Kasahara, Yuki ;

Okada, Yoshinari ;

Imai, Hiroo ;

Komine, Keigo ;

Saijo, Ken ;

Takahashi, Masahiro ;

Shirota, Hidekazu ;

Takahashi, Masanobu ;

Gamoh, Makio ;

Ishioka, Chikashi .

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (04) :790-798

[9] Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer [J].

Reck, Martin ;

Rabe, Klaus F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) :849-861

[10] Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer [J].

Reck, Martin ;

Rodriguez-Abreu, Delvys ;

Robinson, Andrew G. ;

Hui, Rina ;

Csoszi, Tibor ;

Fulop, Andrea ;

Gottfried, Maya ;

Peled, Nir ;

Tafreshi, Ali ;

Cuffe, Sinead ;

O'Brien, Mary ;

Rao, Suman ;

Hotta, Katsuyuki ;

Leiby, Melanie A. ;

Lubiniecki, Gregory M. ;

Shentu, Yue ;

Rangwala, Reshma ;

Brahmer, Julie R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1823-1833

← 1 2 →